Amino acids as metabolic substrates during cardiac ischemia

Experimental Biology and Medicine

Volumn 237, Issue 12, 2012, Pages 1369-1378

  Drake, Kenneth J ^a   Sidorov, Veniamin Y ^a,b   McGuinness, Owen P ^a   Wasserman, David H ^a   Wikswo, John P ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Amino acids; Cardiac; Cardioprotection; Ischemia; Metabolism

Indexed keywords

ACETYL COENZYME A; ALANINE; AMINO ACID; AMINOOXYACETIC ACID; ASPARAGINE; ASPARTIC ACID; CYCLOSERINE; FATTY ACID; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; KETONE BODY; LACTIC ACID; OXYGEN; PYRUVIC ACID; TRIMETAZIDINE;

AMINO ACID METABOLISM; ANOXIA; CARDIOMYOPATHY; CELL DEATH; CHANNELOPATHY; CITRIC ACID CYCLE; ELECTROPHYSIOLOGY; FATTY ACID OXIDATION; GLYCOLYSIS; HEART DEATH; HEART FAILURE; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART PROTECTION; HUMAN; HYPOXIA; ISCHEMIA; MASS SPECTROMETRY; METABOLIC DISORDER; OXIDATIVE PHOSPHORYLATION; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE DRUG DOSE;

AMINO ACIDS; ANIMALS; CARDIOMEGALY; CORONARY VESSELS; HEART FAILURE; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; OXYGEN; OXYGEN CONSUMPTION;

EID: 84873028506     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2012.012025     Document Type: Review

References (56)

1. Taegtmeyer H. Energy-metabolism of the heart-from basic concepts to clinical-applications. Curr Probl Cardiol 1994;19:61-113
2. McDonald TF, Macleod DP. Metabolism and electrical-activity of anoxic ventricular muscle. J Physiol London 1973;229:559-82
3. Nishimura M, Tanaka H, Homma N, Matsuzawa T, Watanabe Y. Ionic mechanisms of the depression of automaticity and conduction in the rabbit atrioventricular node caused by hypoxia or metabolic inhibition and protective action of glucose and valine. Am J Cardiol 1989;64:J24-8
4. Morena H, Janse MJ, Fiolet JWT, Krieger WJG, Crijns H, Durrer D. Comparison of the effects of regional ischemia, hypoxia, hyperkalemia, and acidosis on intracellular and extracellular potentials and metabolism in the isolated porcine heart. Circul Res 1980;46:634-46
5. Liedtke AJ. Alterations of carbohydrate and lipid-metabolism in the acutely ischemic heart. Progress in Cardiovasc Dis 1981;23:321-36
6. Weiss JN, Lamp ST. Glycolysis preferentially inhibits ATP-sensitive K+ channels in isolated Guinea-pig cardiac myocytes. Science 1987;238:67-9
7. Elliott AC, Smith GL, Allen DG. Simultaneous measurements of action potential duration and intracellular ATP in isolated ferret hearts exposed to cyanide. Circ Res 1989;64:583-91
8. Bing RJ, Siegel A, Ungar I, Gilbert M. Metabolism of the human heart II. Studies on fat, ketone and amino acid metabolism. Am J Mede 1954;16:504-15
9. Bing RJ. Cardiac metabolism. Physiol Rev 1965;45:171-213
10. Kodde IF, van der Stok J, Smolenski RT, de Jong JW. Metabolic and genetic regulation of cardiac energy substrate preference. Comp Biochem Phys A Mol Int 2007;146:26-39
11. Rennie MJ, Bowtell JL, Bruce M, Khogali SEO. Interaction between glutamine availability and metabolism of glycogen, tricarboxylic acid cycle intermediates and glutathione. J Nutr 2001;131:2488S-90S
12. Sambandam N, Lopaschuk GD, Brownsey RW, Allard MF. Energy metabolism in the hypertrophied heart. Heart Fail Rev 2002;7:161-73
13. Taegtmeyer H, Goodwin GW, Doenst T, Frazier OH. Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol 1997;80:3A-10A
14. Sorokina N, O'Donnell JM, McKinney RD, Pound KM, Woldegiorgis G, LaNoue KF, Ballal K, Taegtmeyer H, Buttrick PM, Lewandowski ED. Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts. Circulation 2007;115:2033-41
15. Huang Y, Zhou M, Sun H, Wang Y. Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit? Cardiovasc Res 2011;90:220-3
16. Taegtmeyer H, Harinstein ME, Gheorghiade M. More than bricks and mortar: comments on protein and amino acid metabolism in the heart. Am J Cardiol 2008;101(Suppl. S):3E-7E
17. Wischmeyer PE, Jayakar D, Williams U, Singleton KD, Riehm J, Bacha EA, Jeevanandam V, Christians U, Serkova N. Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury. J Parenter Enteral Nutr 2003;27:396-403
18. Bolotin G, Raman J, Williams U, Bacha E, Kocherginsky M, Jeevanandam V. Glutamine improves myocardial function following ischemia-reperfusion injury. Asian Cardiovasc Thorac Ann 2007;15:463-7
19. Stottrup NB, Kristiansen SB, Lofgren B, Hansen BF, Kimose HH, Botker HE, Nielsen TT. L-glutamate and glutamine improve haemodynamic function and restore myocardial glycogen content during postischaemic reperfusion: a radioactive tracer study in the rat isolated heart. Clin Exp Pharmacol Physiol 2006;33:1099-103
20. Liu J, Marchase RB, Chatham JC. Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels. J Mol Cell Cardiol 2007;42:177-85
21. Mudge GH, Mills RM, Taegtmeyer H, Gorlin R, Lesch M. Alterations of myocardial amino-acid metabolism in chronic ischemic heart-disease. J Clin Investig 1976;58:1185-92
22. Schwartz RG, Barrett EJ, Francis CK, Jacob R, Zaret BL. Regulation of myocardial amino-acid balance in the conscious dog. J Clin Investig 1985;75:1204-11
23. Taegtmeyer H, Peterson MB, Ragavan VV, Ferguson AG, Lesch M. De novo alanine synthesis in isolated oxygen-deprived rabbit myocardium. J Biol Chem 1977;252:5010-8
24. Peuhkurinen KJ, Takala TES, Nuutinen EM, Hassinen IE. Tricarboxylic-acid cycle metabolites during ischemia in isolated perfused rat-heart. Am J Physiol 1983;244:H281-8
25. Williams IH, Sugden PH, Morgan HE. Use of aromatic amino acids as monitors of protein turnover. AJP-Endocrinology and Metabolism 1981;240:E677-81
26. Morgan HE, Earl DCN, Broadus A, Wolpert EB, Giger KE, Jefferson LS. Regulation of protein synthesis in heart muscle. I. Effect of amino acid levels on protein synthesis. J Biol Chem 1971;246:2152-2162
27. Lomivorotov VV, Efremov SM, Shmirev VA, Ponomarev DN, Lomivorotov VN, Karaskov AM. Glutamine is cardioprotective in patients with ischemic heart disease following cardiopulmonary bypass. Heart Surg Forum 2011;14:E384-8
28. Cohen DM, Guthrie PH, Gao XL, Sakai R, Taegtmeyer H. Glutamine cycling in isolated working rat heart. Am J Physiol Endocrinol Metab 2003;285:E1312-16
29. Julia P, Young HH, Buckberg GD, Kofsky ER, Bugyi HI. Studies of myocardial protection in the immature heart. II. Evidence for importance of amino acid metabolism in tolerance to ischemia. J Thorac Cardiovasc Surg 1990;100:888-95
30. Opie LH. Metabolic-regulation in ischemia and hypoxia-effects of anoxia and regional ischemia on metabolism of glucose and fatty-acids. Cardiovasc Res 1976;38:52-74
31. Neely JR, Morgan HE. Relationship between carbohydrate and lipid-metabolism and energy-balance of heart-muscle. Annu Rev Physiol 1974;36:413-59
32. Rupert BE, Segar JL, Schutte BC, Scholz TD. Metabolic adaptation of the hypertrophied heart: role of the malate/aspartate and alpha-glycerophosphate shuttles. J Mol Cell Cardiol 2000;32:2287-97
33. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005;85:1093-129
34. Opie LH. Cardiac metabolism-emergence, decline, and resurgence 2. Cardiovasc Res 1992;26:817-30
35. Suleiman MS, Dihmis WC, Caputo M, Angelini GD, Bryan AJ. Changes in myocardial concentration of glutamate and aspartate during coronary artery surgery. AJP Heart Circ Physiol 1997;272:H1063-69
36. Williams H, King N, Griffiths EJ, Suleiman MS. Glutamate-loading stimulates metabolic flux and improves cell recovery following chemical hypoxia in isolated cardiomyocytes. J Mol Cell Cardiol 2001;33:2109-19
37. Todorova V, Vanderpool D, Blossom S, Nwokedi E, Hennings L, Mrak R, Klimberg VS. Oral glutamine protects against cyclophosphamide-induced cardiotoxicity in experimental rats through increase of cardiac glutathione. Nutrition 2009;25:812-7
38. Engel JM, Muhling J, Kwapisz M, Heidt M. Glutamine administration in patients undergoing cardiac surgery and the influence on blood glutathione levels. Acta Anaesthesiol Scand 2009;53:1317-23
39. McGuinness J, Neilan TG, Cummins R, Sharkasi A, Bouchier-Hayes D, Redmond JM. Intravenous glutamine enhances COX-2 activity giving cardioprotection. J S Res 2009;152:140-7
40. Hissa MN, Vasconcelos RCd, Guimarães SB, Silva RP, Garcia JHP, Vasconcelos PRLd. Preoperative glutamine infusion improves glycemia in heart surgery patients. Acta Cir Bras 2011;26:77-81
41. Dinkelborg LM, Kinne RKH, Grieshaber MK. Transport and metabolism of L-glutamate during oxygenation, anoxia, and reoxygenation of rat cardiac myocytes. Am J Physiol Heart Circ Physiol 1996;39:H1825-32
42. Malandro MS, Kilberg MS. Molecular biology of mammalian amino acid transporters. Annu Rev Biochem 1996;65:305-36
43. Razeghi P, Sharma S, Ying J, Li YP, Stepkowski S, Reid MB, Taegtmeyer H. Atrophic remodeling of the heart in vivo simultaneously activates pathways of protein synthesis and degradation. Circulation 2003;108:2536-41
44. Schelbert HR, Phelps ME, Huang SC, Macdonald NS, Hansen H, Kuhl DE. N-13 ammonia as an indicator of myocardial blood-flow. Circulation 1981;63:1259-72
45. Burgess SC, Babcock EE, Jeffrey FMH, Sherry AD, Malloy CR. NMR indirect detection of glutamate to measure citric acid cycle flux in the isolated perfused mouse heart. FEBS Lett 2001;505:163-7
46. Noguchi Y, Young JD, Aleman JO, Hansen ME, Kelleher JK, Stephanopoulos G. Effect of anaplerotic fluxes and amino acid availability on hepatic lipoapoptosis. J Biol Chem 2009;284:33425-36
47. Enders JR, Goodwin CR, Marasco CC, Seale KT, Wikswo JP, Mclean JA. Advanced structural mass spectrometry for systems biology: pulling the needles from haystacks. Spectrosc Supp Curr Trends Mass Spectrom 2011:18-23
48. Enders JR, Kliman M, Sundarapandian S, Mclean JA. Peptide and protein analysis using ion mobility-mass spectrometry. In: Gross ML, Chen G, Pramanik B, eds. Peptide and Protein Mass Spectrometry in Drug Discovery. Hoboken, NJ, John Wiley & Sons, Inc., 2011:139-174
49. Enders JR, Marasco CC, Kole A, Nguyen B, Sundarapandian S, Seale KT, Wikswo JP, Mclean JA. Towards monitoring real-time cellular response using an integrated microfluidics-MALDI/NESI-ion mobility-mass spectrometry platform. IET Syst Biol 2010;4:416-27
50. Goodwin CR, Fenn LS, Derewacz DK, Bachmann BO, McLean JA. Structural mass spectrometry: rapid methods for separation and analysis of peptide natural products. J Nat Prod 2012;75:48-53
51. Kerr TJ, McLean JA. Peptide quantitation using primary amine selective metal chelation labels for mass spectrometry. Chem Commun 2010;46:5479-81
52. Marzilli M, Affinito S. Evidence of efficacy of metabolic agents. Heart Metab 2005;27:21-3
53. Marzilli M. Trimetazidine: a metabolic agent for the treatment of stable angina. Euro Heart J Suppl 2001;3:O12-5
54. Lee J, Niederer S, Nordsletten D, Le Grice I, Smail B, Kay D, Smith N. Coupling contraction, excitation, ventricular and coronary blood flow across scale and physics in the heart. Philos Trans R Soc London A 2009;367:2311-31
55. Niederer SA, Fink M, Noble D, Smith NP. A meta-analysis of cardiac electrophysiology computational models. Exp Physiol 2009;94:486-95
56. Fink M, Niederer SA, Cherry EM, Fenton FH, Koivumäki JT, Seemann G, Thul R, Zhang H, Sachse FB, Beard D, Crampin EJ, Smith NP. Cardiac cell modelling: Observations from the heart of the cardiac physiome project. Prog Biophys Mol Biol 2011;104:2-21